LUXEMBOURG, April 24, 2025 /PRNewswire/ -- Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), a leading innovator in sports and health tech, delivering advanced wearable AIoT solutions that seamlessly merge athletic performance monitoring with real-time health insights, is pleased to announce Hubertus "Bert" Hoyt as its newest Board Advisor.
Bert is a renowned sports industry expert with over 32 years of experience. His extensive background working with some of the world's most iconic sports brands and elite athletes will bring invaluable strategic insights to dBio's Board, supporting its mission to revolutionize personalized healthcare and fitness technologies worldwide.
dBio: Leading the Future of Health and Exercise Management
Dedicated to empowering individuals to better understand their bodies, dBio helps users optimize training, accelerate recovery, and reduce injury risk through personalized, data-driven feedback.
At the core of dBio's platform are its proprietary technologies: gMOTCloud, the original AI-powered kinesiology wearable capturing detailed motion and gait metrics, and StethoCloud, a lightweight wearable stethoscope enabling continuous heart and respiratory monitoring with AI-enhanced noise reduction. Collectively, these devices offer cloud-based analytics and virtual coaching support for healthier, safer, and more effective performance in exercise.
With more than 75 registered patents and a fully self-developed ecosystem spanning AI modeling, hardware, software, and app development, dBio delivers a comprehensive solution for performance optimization and health management, suitable for elite athletes to fitness enthusiasts, and across applications in telemedicine, rehabilitation, and elder care. Further, dBio's technology is supported by strategic partnerships with leaders across the medical, academic, and athletic sectors. As dBio continues to expand its global footprint, it aims to redefine the future of personalized health and performance technology.
Hubertus "Bert" Hoyt: A Proven Innovator in Global Brand Building
Bert began his career in 1989 at Puma, where he rose through the ranks from product management to business leadership for the brand. He eventually served as General Manager of Puma International, playing a key role in driving the company's exceptional growth between 1992 and 1998.
In 1998, Bert joined Nike, where he spent 22 years as a senior executive. His leadership roles spanned brand management, business unit general management, and global category management, culminating in nine years as Vice President & General Manager of Nike Western Europe and EMEA. Bert was instrumental in transforming Nike Germany, Global Football, and Western Europe, ultimately leading Nike EMEA to market leadership.
He is particularly known for his deep understanding of consumer needs and his ability to align teams to a clear and compelling consumer vision. Bert's unwavering focus on serving athletes with the best products and brand experiences helped Nike Western Europe grow from US$3 billion to US$7 billion, with EMEA reaching over US$10 billion in revenue and achieving a 24% EBIT.
Since his retirement from Nike in early 2021, Bert has served as a non-executive Director at JD Sports PLC, Crius Bidco Limited (owner of Zelus Sport Limited, a Nike licensee), Mast-Jaegermeister SE, and Cosnova GmbH (Beauty & Makeup). In addition to his impressive corporate career, Bert is a former ATP tennis professional, competing from 1977 to 1984.
"During my personal and business life I have been involved in helping athletes improve their performance and overall well-being. That's why I decided to join dBio as an Advisor, as I believe their innovations will provide that next chapter for athlete performance and provide sports enthusiasts the precise data to improve and help them manage their overall well-being."
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Former Nike VP & GM Bert Hoyt Joins dBio to Drive Next-Gen Sports & Health Tech as Board Advisor
Former Nike VP & GM Bert Hoyt Joins dBio to Drive Next-Gen Sports & Health Tech as Board Advisor
SINGAPORE, May 15, 2025 /PRNewswire/ -- Brilliance Capital Pte. Ltd. is proud to present to the market an exceptionally rare opportunity to acquire a freehold commercial building with individual strata titles per floor at 562 Serangoon Road, a highly visible and well-positioned property located in the heart of one of Singapore's most vibrant and culturally rich city fringe districts.
This four-storey commercial property occupies a land area of approximately 2,336 square feet and offers a total floor area of approximately 7,453 square feet, with individual strata titles for each level. The building presents a rare opportunity to acquire a freehold, non-conserved commercial asset with approved F&B use on the ground floor, making it highly attractive for a variety of investor profiles including owner-occupiers, landlords, corporates, hospitality operators, and family offices.
What truly distinguishes this property is its non-conserved status, an exceptional rarity along this stretch of Serangoon Road that is otherwise lined with conserved shophouses under architectural controls. As a Non-Conserved Envelope Control Site within a Secondary Settlement and zoned "Commercial" under the 2019 URA Master Plan with a plot ratio of 3.0, the site offers the buyer maximum flexibility to reconfigure, reposition, or redevelop the property to suit modern business needs. Subject to authorities' approvals, this opens the door to future-proofed uses such as serviced apartments, co-living residences, lifestyle clinics, co-working spaces, or creative concept showrooms, depending on owner and/or tenant demands and market trends.
Adding to its desirability is the building's ground-floor restaurant use approval, a tightly regulated designation in many central precincts. With F&B use already in place, owners can either operate their own flagship outlet or command premium rents from established tenants seeking main-road visibility in a city-fringe location.
The building's strata title per floor enhances its long-term investment appeal, offering flexibility for multi-use configurations or future strata divestment. This structure gives investors the freedom to either hold and lease the building as a whole or sell individual floors strategically over time. Few commercial properties in Singapore today combine such flexibility, rarity of tenure, and redevelopment potential in one asset. The guide price is set at a palatable S$23.5 million, in line with the latest valuation, offering exceptional value for a freehold standalone commercial building in a city-fringe locale with such versatile attributes.
Strategically located within a five-minute walk from both Farrer Park MRT Station and Boon Keng MRT Station (North-East Line), the property enjoys excellent connectivity and exposure, situated directly along Serangoon Road which is a major arterial road that channels strong pedestrian and vehicular traffic daily. The site is also well connected to key expressways including the CTE and PIE, and is within a short drive to popular areas such as Little India, Farrer Park, Bidadari, and the Kallang Riverside precinct.
Shopping malls such as City Square Mall and Mustafa Centre Mall are within a short walk, providing convenient access to daily essentials, dining, and entertainment. The area is also anchored by established medical and wellness hubs including Connexion at Farrer Park, an integrated healthcare and hospitality development comprising Farrer Park Hospital and One Farrer Hotel, as well as the Kwong Wai Shiu Hospital nearby. These major facilities not only draw a steady stream of visitors and medical tourists, but also support demand from wellness, aesthetic, and specialist clinics. Additionally, lifestyle enclaves such as Little India, Kampong Glam, and the emerging Boon Keng–Bendemeer precinct inject vibrancy into the district, while surrounding residential estates including HDB clusters in Whampoa and Boon Keng, and private developments like City Square Residences, Sturdee Residences, and 8 Riversuites, ensure a constant local population that drives daily footfall and commercial demand.
The broader Serangoon–Boon Keng–Lavender corridor is undergoing steady transformation, with new residential projects, community upgrades, and commercial developments on the horizon. This evolving landscape is expected to uplift overall land values and rental yields in the district, offering buyers strong future growth potential both in terms of capital appreciation and income.
"This is one of those real estate opportunities that checks all the right boxes," says Ms Sammi Lim, Founder and Executive Director of Brilliance Capital Pte. Ltd. "562 Serangoon Road offers freehold tenure, F&B approval, strata flexibility, and the freedom to enhance or reposition the building without conservation constraints. It is truly a rare gem. In today's tightly held urban market, finding a non-conserved commercial asset with such prominence and potential is incredibly rare."
She adds, "With its prime location near key districts, 562 Serangoon Road stands out as a highly desirable investment and owner-occupier asset. It offers excellent accessibility, high foot traffic, and strong future growth potential. For investors looking to unlock value over time, or businesses wanting their own city-fringe headquarters with branding visibility and upside, this is an asset not to be missed."
The property's pure commercial zoning ensures that the acquisition is not subject to Additional Buyer's Stamp Duty (ABSD) or Seller's Stamp Duty (SSD), a distinct advantage for both local and foreign buyers. This investment is suitable for a wide range of profiles, from private investors, corporates and family offices to developers and institutional funds looking for a unique foothold in central Singapore.
Brilliance Capital is the sole marketing agent for this Expression of Interest.
The Expression of Interest closes on 9 July 2025, Wednesday at 3:00 p.m.
Note to editors:
One high-resolution photograph of the properties are enclosed.
About Brilliance Capital Pte. Ltd.
Brilliance Capital is a premier real estate agency specializing in bespoke advisory and transaction services for high-net-worth individuals, family offices, property developers, and institutions in Singapore and globally.
Founded and led by Sammi Lim, a veteran in Singapore's property landscape , our team of top-tier professionals excels in selling and leasing luxury residential, commercial, and industrial properties, as well as collective sales. We also offer tailored consultancy and advisory services, addressing personal, professional, and investment needs with precision and care.
Backed by deep market insight and a robust international network, Brilliance Capital is dedicated to building lasting relationships and delivering exceptional real estate outcomes.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
FOR SALE BY EXPRESSION OF INTEREST: Freehold Non-Conserved Commercial Building at 562 Serangoon Road
